HR 7567
Helping Experts Accelerate Rare Treatments Act of 2020
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Helping Experts Accelerate Rare Treatments Act of 2020 aims to improve the treatment of rare diseases by requiring the Food and Drug Administration (FDA) to incorporate rare disease experts into its drug review processes. It mandates an annual report detailing the FDA’s activities related to orphan drugs, including application numbers, disease prevalence, and expert consultations. The bill also directs the Comptroller General to study how the European Union reviews drugs for rare diseases and to recommend changes to the FDA’s processes to facilitate treatment development and access.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
David B. McKinley
Michael F. Q. [D-GU-At Large] San Nicolas
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.